MedPath

A prospective cohort study of mineral and bone disorder in hemodialysis patients

Not Applicable
Conditions
chronic renal failure
Registration Number
JPRN-UMIN000000556
Lead Sponsor
Kidney Care Unit in Kyushu University Hospital
Brief Summary

The risks of both cardiovascular desease and bone fracture in vitamin D treated group were significantly higher than those in non-treated group. The risks of both cardiovascular desease and bone fracture inreased in the hyperparathyroidism patients, but not in the hypoparathyroidism patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
3000
Inclusion Criteria

Not provided

Exclusion Criteria

The patients who do not agree with this study The patients who are unsuitable for this study

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
All-cause mortality
Secondary Outcome Measures
NameTimeMethod
The influence of dialysate calcium concentration on the mortality , cardiovascular disease, bone fracture in hemodialysis patients The influence of dialysis time on either the mortality or the condition in hemodialysis patients The influence of vitamin D therapy on either the mortality or the condition in hemodialysis patients The risk factor of mortaliry, cardiaovascular disease and bone fracture in hemodialysis patients The relationship between PTH/PTH fragment and the condition of hemodialysis patiens The change of the condition by newly drugs in hemodialysis patients
© Copyright 2025. All Rights Reserved by MedPath